Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?

Affiliations

Comment

Linda S Cox. JAMA. 2017.

. 2017 Feb 14;317(6):591-593.

doi: 10.1001/jama.2017.0128.

¹ University of Miami Miller School of Medicine at Holy Cross Hospital, Ft Lauderdale, Florida.

Erratum in

Misstated Text.
[No authors listed] [No authors listed] JAMA. 2017 Mar 21;317(11):1179. doi: 10.1001/jama.2017.1785. JAMA. 2017. PMID: 28241213 No abstract available.

No abstract available

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, Sever ML, Bahnson HT, Lawson K, Harris KM, Plough AG, Panza JL, Qin T, Lim N, Tchao NK, Togias A, Durham SR; Immune Tolerance Network GRASS Study Team. Scadding GW, et al. JAMA. 2017 Feb 14;317(6):615-625. doi: 10.1001/jama.2016.21040. JAMA. 2017. PMID: 28196255 Free PMC article. Clinical Trial.